1. A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression
- Author
-
Hyun Guy Kang, Yi Jun Kim, Kyoung Min Lee, Yongsik Cho, Jin-Hong Kim, Moon Jong Chang, Chong Bum Chang, Donghyeon Cheon, Hyeon Seop Kim, Hyeonkyeong Kim, Donghyun Kang, and Seung Baik Kang
- Subjects
musculoskeletal diseases ,0301 basic medicine ,animal structures ,Science ,Chondrosarcoma ,Regulator ,Mice, Nude ,General Physics and Astronomy ,Bone Neoplasms ,Malignancy ,Article ,General Biochemistry, Genetics and Molecular Biology ,Metastasis ,03 medical and health sciences ,Targeted therapies ,0302 clinical medicine ,Cell Line, Tumor ,Antineoplastic Combined Chemotherapy Protocols ,Basic Helix-Loop-Helix Transcription Factors ,medicine ,Animals ,Humans ,Gene Regulatory Networks ,lcsh:Science ,Regulation of gene expression ,Multidisciplinary ,business.industry ,EPAS1 Gene ,Cancer ,Sarcoma ,General Chemistry ,musculoskeletal system ,medicine.disease ,Xenograft Model Antitumor Assays ,Isocitrate Dehydrogenase ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,Tumor progression ,030220 oncology & carcinogenesis ,embryonic structures ,Cancer research ,Benzimidazoles ,Female ,lcsh:Q ,Cisplatin ,business - Abstract
Chondrosarcomas, malignant cartilaginous neoplasms, are capable of transitioning to highly aggressive, metastatic, and treatment-refractory states, resulting in significant patient mortality. Here, we aim to uncover the transcriptional program directing such tumor progression in chondrosarcomas. We conduct weighted correlation network analysis to extract a characteristic gene module underlying chondrosarcoma malignancy. Hypoxia-inducible factor-2α (HIF-2α, encoded by EPAS1) is identified as an upstream regulator that governs the malignancy gene module. HIF-2α is upregulated in high-grade chondrosarcoma biopsies and EPAS1 gene amplification is associated with poor prognosis in chondrosarcoma patients. Using tumor xenograft mouse models, we demonstrate that HIF-2α confers chondrosarcomas the capacities required for tumor growth, local invasion, and metastasis. Meanwhile, pharmacological inhibition of HIF-2α, in conjunction with the chemotherapy agents, synergistically enhances chondrosarcoma cell apoptosis and abolishes malignant signatures of chondrosarcoma in mice. We expect that our insights into the pathogenesis of chondrosarcoma will provide guidelines for the development of molecular targeted therapeutics for chondrosarcoma., Chondrosarcomas are frequently aggressive, understanding the transcriptional changes associated with progression may help in developing new treatments. Here, the authors show that HIF-2α is increased in expression on progression and pharmacological inhibition of the protein together with chemotherapy is a useful strategy for controlling tumour growth in mice.
- Published
- 2020
- Full Text
- View/download PDF